Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the Alzheimer’s Association recommended guidelines: brain-derived phosphorylated tau [...]

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors Fremont, Calif. –  Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed [...]

Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery

Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studies BOSTON & LAUSANNE, Switzerland -- Genialis, the RNA biomarker company, today announced that Swiss-based biopharmaceutical company Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support biomarker discovery and [...]

M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio

London – M&G Investments (M&G) today announces that it is leading a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming technology. The investment of patient capital into a fast-growing private UK company, spun out from the University of Cambridge, marks a major vote of confidence in [...]

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering WALTHAM, Mass. --  Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating [...]

Elemental Machines Introduces Its Next Evolution with Launch of New Agentic AI Platform

CAMBRIDGE, Mass. — Elemental Machines, a pioneer in life sciences operational intelligence, today announced the next evolution of its operations with the expanded launch of its Agentic AI Platform. This release transforms how laboratories and manufacturing facilities turn equipment, facility, and environmental data into strategic decisions to improve operational efficiency. The first two Elemental Machines’ [...]

Illumina and PREMIA partner to expand clinical access to CGP in Asia

TAIPEI -- Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer clinical-genomic screening network, today announced the formation of a strategic partnership that will expand access to comprehensive genomic profiling (CGP) for all eligible oncology patients across the Chang Gung Memorial Hospital (CGMH) system. This partnership also aims to support the [...]

Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

Collaboration makes AI models trained on over $1 billion in Lilly research data accessible directly in scientists' workflows SAN FRANCISCO -- Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and Company (Lilly) to provide access to models trained on decades [...]

Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

Veeva’s expanded manufacturing QC solutions to automate environmental sample collection and analysis PLEASANTON, CA — Veeva Systems (NYSE: VEEV) today announced a new environmental monitoring (EM) solution to advance quality control (QC) for manufacturing operations. Veeva Environmental Monitoring, a cloud-native application unified with Veeva LIMS, will enable laboratories and manufacturing facilities to schedule, collect, and analyze environmental samples [...]

L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster, from strategy to measurable outcomes. AUSTIN, TX and MINNEAPOLIS, MN – L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives [...]

Access IBO on Knowledge Center